Stay updated on Alirocumab for Plaque Regression in PAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.

Latest updates to the Alirocumab for Plaque Regression in PAD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check24 days agoChange DetectedA site-wide NIH notice explains that federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to transition updates and FAQs.SummaryDifference0.7%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry for v3.7.0 was added to the record history and the prior v3.6.6 entry was removed from the visible list, reflecting a recent update to the record documentation.SummaryDifference0.1%

- Check79 days agoChange DetectedA new page revision entry (v3.6.6) is added to the record history, replacing the previous revision (v3.6.5) and reflecting an update to the study record page.SummaryDifference0.1%

Stay in the know with updates to Alirocumab for Plaque Regression in PAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.